205 related articles for article (PubMed ID: 16207737)
1. Pacemaker selection: time for a rethinking of complex pacing systems?
Musilli N; Padeletti L
Eur Heart J; 2006 Jan; 27(2):132-5. PubMed ID: 16207737
[TBL] [Abstract][Full Text] [Related]
2. Role of permanent pacing to prevent atrial fibrillation: science advisory from the American Heart Association Council on Clinical Cardiology (Subcommittee on Electrocardiography and Arrhythmias) and the Quality of Care and Outcomes Research Interdisciplinary Working Group, in collaboration with the Heart Rhythm Society.
Knight BP; Gersh BJ; Carlson MD; Friedman PA; McNamara RL; Strickberger SA; Tse HF; Waldo AL; ; ; ;
Circulation; 2005 Jan; 111(2):240-3. PubMed ID: 15657388
[TBL] [Abstract][Full Text] [Related]
3. Increased base rate of atrial pacing for prevention of atrial fibrillation after implantation of a dual-chamber pacemaker: insights from the Atrial Overdrive Pacing Study.
Kantharia BK; Freedman RA; Hoekenga D; Tomassoni G; Worley S; Sorrentino R; Steinhaus D; Wolkowicz JM; Syed ZA;
Europace; 2007 Nov; 9(11):1024-30. PubMed ID: 17913697
[TBL] [Abstract][Full Text] [Related]
4. The MINERVA study design and rationale: a controlled randomized trial to assess the clinical benefit of minimizing ventricular pacing in pacemaker patients with atrial tachyarrhythmias.
Funck RC; Boriani G; Manolis AS; Püererfellner H; Mont L; Tukkie R; Pisapia A; Israel CW; Grovale N; Grammatico A; Padeletti L;
Am Heart J; 2008 Sep; 156(3):445-51. PubMed ID: 18760124
[TBL] [Abstract][Full Text] [Related]
5. Atrial vs. dual-chamber cardiac pacing in sinus node disease: a register-based cohort study.
Fored CM; Granath F; Gadler F; Blomqvist P; Rynder J; Linde C; Ekbom A; Rosenqvist M
Europace; 2008 Jul; 10(7):825-31. PubMed ID: 18467299
[TBL] [Abstract][Full Text] [Related]
6. Multicenter, prospective, randomized safety and efficacy study of a new atrial-based managed ventricular pacing mode (MVP) in dual chamber ICDs.
Sweeney MO; Ellenbogen KA; Casavant D; Betzold R; Sheldon T; Tang F; Mueller M; Lingle J;
J Cardiovasc Electrophysiol; 2005 Aug; 16(8):811-7. PubMed ID: 16101620
[TBL] [Abstract][Full Text] [Related]
7. Selecting the appropriate pacing mode for patients with sick sinus syndrome: evidence from randomized clinical trials.
Albertsen AE; Nielsen JC
Card Electrophysiol Rev; 2003 Dec; 7(4):406-10. PubMed ID: 15071265
[TBL] [Abstract][Full Text] [Related]
8. The role of pacing mode in the development of atrial fibrillation.
Israel CW
Europace; 2006 Feb; 8(2):89-95. PubMed ID: 16627416
[TBL] [Abstract][Full Text] [Related]
9. Dynamic and dual-site atrial pacing in the prevention of atrial fibrillation: The STimolazione Atrial DInamica Multisito (STADIM) Study.
De Simone A; Senatore G; Donnici G; Turco P; Romano E; Gazzola C; Stabile G
Pacing Clin Electrophysiol; 2007 Jan; 30 Suppl 1():S71-4. PubMed ID: 17302722
[TBL] [Abstract][Full Text] [Related]
10. Reducing unnecessary right ventricular pacing with the managed ventricular pacing mode in patients with sinus node disease and AV block.
Gillis AM; Pürerfellner H; Israel CW; Sunthorn H; Kacet S; Anelli-Monti M; Tang F; Young M; Boriani G;
Pacing Clin Electrophysiol; 2006 Jul; 29(7):697-705. PubMed ID: 16884504
[TBL] [Abstract][Full Text] [Related]
11. Pacing for the prevention of atrial fibrillation.
Gillis AM; Kerr CR; Crystal E
Can J Cardiol; 2005 Sep; 21 Suppl B():41B-44B. PubMed ID: 16239987
[TBL] [Abstract][Full Text] [Related]
12. Impact of atrial antitachycardia pacing and atrial pace prevention therapies on atrial fibrillation burden over long-term follow-up.
Gillis AM; Morck M; Exner DV; Sheldon RS; Duff HJ; Mitchell BL; Wyse GD
Europace; 2009 Aug; 11(8):1041-7. PubMed ID: 19460849
[TBL] [Abstract][Full Text] [Related]
13. A new dual-chamber pacing mode to minimize ventricular pacing.
Savouré A; Fröhlig G; Galley D; Defaye P; Reuter S; Mabo P; Sadoul N; Amblard A; Limousin M; Anselme F
Pacing Clin Electrophysiol; 2005 Jan; 28 Suppl 1():S43-6. PubMed ID: 15683522
[TBL] [Abstract][Full Text] [Related]
14. Atrial fibrillation and quality of life after pacemaker implantation for sick sinus syndrome: data from the Mode Selection Trial (MOST).
Fleischmann KE; Orav EJ; Lamas GA; Mangione CM; Schron EB; Lee KL; Goldman L;
Am Heart J; 2009 Jul; 158(1):78-83.e2. PubMed ID: 19540395
[TBL] [Abstract][Full Text] [Related]
15. [Protection systems of dual-chamber pacemakers against atrial arrhythmia].
Deharo JC; Macaluso G; Djiane P
Arch Mal Coeur Vaiss; 1996 Apr; 89(4):465-70. PubMed ID: 8763007
[TBL] [Abstract][Full Text] [Related]
16. ASymptomatic atrial fibrillation and Stroke Evaluation in pacemaker patients and the atrial fibrillation Reduction atrial pacing Trial (ASSERT).
Hohnloser SH; Capucci A; Fain E; Gold MR; van Gelder IC; Healey J; Israel CW; Lau CP; Morillo C; Connolly SJ;
Am Heart J; 2006 Sep; 152(3):442-7. PubMed ID: 16923410
[TBL] [Abstract][Full Text] [Related]
17. The Managed Ventricular pacing versus VVI 40 Pacing (MVP) Trial: clinical background, rationale, design, and implementation.
Sweeney MO; Ellenbogen KA; Miller EH; Sherfesee L; Sheldon T; Whellan D
J Cardiovasc Electrophysiol; 2006 Dec; 17(12):1295-8. PubMed ID: 17081208
[TBL] [Abstract][Full Text] [Related]
18. Single chamber atrial pacing: a realistic option in sinus node disease: a long-term follow-up study of 213 patients.
Höijer CJ; Höglund P; Schüller H; Brandt J
Pacing Clin Electrophysiol; 2007 Jun; 30(6):740-7. PubMed ID: 17547606
[TBL] [Abstract][Full Text] [Related]
19. Long-term clinical performance of AAI pacing in patients with sick sinus syndrome: a comparison with dual-chamber pacing.
Masumoto H; Ueda Y; Kato R; Usui A; Maseki T; Takagi Y; Usui M
Europace; 2004 Sep; 6(5):444-50. PubMed ID: 15294270
[TBL] [Abstract][Full Text] [Related]
20. Single chamber ventricular compared with dual chamber pacing: a review.
Wong GC; Hadjis T
Can J Cardiol; 2002 Mar; 18(3):301-7. PubMed ID: 11907619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
